Dow Jones

38 686,32

1,51%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Rxi Pharmaceuticals Corp. (MM) (RXII)
Rxi Pharmaceuticals Corp. (MM) (RXII) Actualités

RXII

RXI Pharmaceuticals Corporation (RXII)

Rxi Pharmaceuticals Corp. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:RXII

1 2 3 4 5 6 7 8 9 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
15/02/2019	13h15	PR Newswire (US)	Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
10/12/2018	15h35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
19/11/2018	23h52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	13h10	PR Newswire (US)	RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/11/2018	13h08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
07/11/2018	13h05	PR Newswire (US)	RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell T...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
06/11/2018	13h05	PR Newswire (US)	RXi Pharmaceuticals to Webcast Third Quarter 2018 Financial Results on Wednesday, November 14, 2018	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
10/10/2018	20h00	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/10/2018	22h31	PR Newswire (US)	RXi Pharmaceuticals Announces Closing Of $15 Million Underwritten Public Offering	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/10/2018	23h32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/10/2018	23h30	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/10/2018	12h39	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/10/2018	12h36	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/10/2018	12h10	PR Newswire (US)	RXi Pharmaceuticals Announces Pricing Of $15 Million Upsized Underwritten Public Offering	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
28/09/2018	12h14	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
26/09/2018	14h00	PR Newswire (US)	RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intra...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/09/2018	23h48	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
31/08/2018	23h32	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
28/08/2018	15h15	PR Newswire (US)	RXi Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
24/08/2018	23h04	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
17/08/2018	23h02	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
15/08/2018	15h25	PR Newswire (US)	RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
14/08/2018	15h15	PR Newswire (US)	RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
07/08/2018	13h15	PR Newswire (US)	RXi Pharmaceuticals to Webcast Second Quarter 2018 Financial Results on Tuesday, August 14, 2018	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/08/2018	15h25	PR Newswire (US)	RXi Pharmaceuticals Granted Patents for sd-rxRNA Technology Strengthening Intellectual Property Estate in Europe and Japan	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/08/2018	15h25	PR Newswire (US)	RXi Pharmaceuticals Announces Positive Results From Phase 1/2 Trial With RXI-109 For Retinal Scarring	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
28/06/2018	14h00	PR Newswire (US)	BioAxone BioSciences Awarded $1.1 Million Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate for the T...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
18/05/2018	17h58	PR Newswire (US)	RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with Samcyprone™ for the Treatment of Common Warts	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
11/05/2018	13h05	PR Newswire (US)	RXi Pharmaceuticals Enters into Material Transfer Agreement with Iovance Biotherapeutics to Study its Self-Delivering RNAi Te...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
10/05/2018	13h05	PR Newswire (US)	RXi Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Corporate Highlights	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)